Tumor promoting effects of CD95 signaling in chemoresistant cells
Elisabet Ametller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Vanessa Almendro(Danaher (United States))
Cited by 25
Related Papers
Intra-tumour heterogeneity: a looking glass for cancer?
|Nature reviews. Cancer|2012|2k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928
Cellular Heterogeneity and Molecular Evolution in Cancer
|Annual Review of Pathology Mechanisms of Disease|2012|510